Drug class
Long-acting phenothiazine antipsychotic; dopamine-receptor antagonist
Mechanism of action
Blocks postsynaptic dopamine receptors, particularly D2-family receptors, and also interacts with serotonergic, histaminergic, adrenergic and muscarinic receptors. Depot formulations provide prolonged antipsychotic exposure.
General use cases
- Maintenance treatment of schizophrenia and other chronic psychotic disorders with long-acting injectable formulations where authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
